Livzon Pharmaceutical Group Inc. (SHE:000513)
China flag China · Delayed Price · Currency is CNY
34.53
+0.38 (1.11%)
Apr 8, 2026, 3:04 PM CST

SHE:000513 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
27,74427,95030,70428,29227,45632,307
Market Cap Growth
0.27%-8.97%8.53%3.04%-15.02%-2.56%
Enterprise Value
21,54222,22724,77322,70022,29727,114
Last Close Price
34.1534.4636.9332.8029.1934.71
PE Ratio
15.0713.8114.9014.4814.3818.19
Forward PE
14.5913.4015.8317.2516.3618.28
PS Ratio
2.312.332.602.282.172.68
PB Ratio
1.781.802.061.921.842.26
P/TBV Ratio
2.092.102.302.102.082.56
P/FCF Ratio
10.7910.8712.7511.6514.9854.46
P/OCF Ratio
8.828.8910.318.719.9016.98
PEG Ratio
-1.131.131.131.131.13
EV/Sales Ratio
1.791.852.101.831.772.25
EV/EBITDA Ratio
6.747.018.018.288.7011.58
EV/EBIT Ratio
8.208.469.7711.8111.5414.14
EV/FCF Ratio
8.388.6510.299.3512.1745.71
Debt / Equity Ratio
0.200.200.270.280.240.19
Debt / EBITDA Ratio
0.960.961.281.501.401.14
Debt / FCF Ratio
1.191.191.651.711.984.54
Net Debt / Equity Ratio
-0.51-0.51-0.46-0.49-0.46-0.46
Net Debt / EBITDA Ratio
-2.48-2.48-2.24-2.65-2.69-2.83
Net Debt / FCF Ratio
-3.06-3.06-2.88-2.99-3.77-11.18
Asset Turnover
0.500.500.480.500.540.56
Inventory Turnover
2.322.322.092.332.472.74
Quick Ratio
1.991.991.871.861.971.83
Current Ratio
2.232.232.152.132.302.12
Return on Equity (ROE)
15.83%15.83%15.53%12.78%13.37%13.97%
Return on Assets (ROA)
6.78%6.78%6.40%4.81%5.11%5.58%
Return on Invested Capital (ROIC)
27.79%28.26%26.92%19.70%20.64%25.12%
Return on Capital Employed (ROCE)
15.70%15.70%15.10%11.30%11.10%12.40%
Earnings Yield
7.29%7.24%6.71%6.91%6.95%5.50%
FCF Yield
9.27%9.20%7.85%8.58%6.67%1.84%
Dividend Yield
4.15%4.15%2.98%4.12%5.48%3.75%
Payout Ratio
51.06%51.06%65.03%81.36%83.33%70.81%
Buyback Yield / Dilution
2.96%2.96%1.10%0.56%0.04%0.25%
Total Shareholder Return
7.11%7.11%4.08%4.68%5.52%4.00%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.